Showing results (721-730 of 863) with videos related to

Sort By:
Pageof 87
Thorax|September 1, 1986
Short duration combination chemotherapy in the treatment of small cell lung cancerA J Dorward, S W Banham, A W Hutcheon, et al.
American Journal of Preventive Medicine|March 14, 2026
Sociodemographic Status and Interest in Public Health Work Post-Medical Training in First-Year Medical Students: A Cross-Sectional StudyAllison Aviles, Frank D Buono, Shayna D Cunningham, et al.
PLOS Global Public Health|February 26, 2026
Community health knowledge and access to care in post-conflict Northern Uganda: Perspectives of community health workers in Pader DistrictBrett R Albee, Patrick Kasagara Atiya, Otema Denish, et al.
British Journal of Cancer|January 1, 1997
A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomasA Rigg, D Cunningham, M Gore, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 31, 2020
Postoperative chemotherapy improves survival in patients with resected high-risk Stage II colorectal cancer: results of a systematic review and meta-analysisC Simillis, H K S I Singh, T Afxentiou, et al.
British Journal of Cancer|September 15, 2004
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapyI Chau, A R Norman, D Cunningham, et al.
British Journal of Cancer|June 2, 2005
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECFK Sumpter, C Harper-Wynne, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphomaA M Seymour, E de Campos, N Thatcher, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1996
The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndromeC G Cochrane, S D Revak, T A Merritt, et al.
British Journal of Cancer|April 3, 2003
Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancerI Chau, M Allen, D Cunningham, et al.
Pageof 87